DrugMonitor™ Rabbit Anti-AT-7519 Antibody (VS-0125-YC308) (CAT#: VS-0125-YC308)

AT7519 is a targeted inhibitor of specific cyclin-dependent kinases (CDKs), contributing to tumor regression, and is being developed to treat solid tumors and hematological malignancies. This product is the DrugMonitor™ Anti-AT-7519 Antibody (VS-0125-YC308), specifically designed as an anti-drug antibody (ADA) that targets AT-7519. The ADA was raised in rabbits immunized with AT-7519 conjugated to BSA and is suitable for use in ELISA and lateral flow assays. This antibody may be employed in pharmacokinetics (PK) and pharmacodynamics (PD) analyses, or as a reference standard in ADA assays. Furthermore, as a drug-based antibody, it serves as an exemplary tool for therapeutic drug monitoring, facilitating the determination of AT-7519 drug concentrations in various samples.